A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases

Clinical trial NCT06255028 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06255028
Sponsor: Century Therapeutics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Lupus Nephritis Idiopathic Inflammatory Myopathies Diffuse Cutaneous Systemic Sclerosis

Start date: 2025-02-06
Primary completion: 2028-08-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.